A recently implanted left ventricular lead was fixated in the coronary sinus due to thrombosis while attempting to reposition the lead because of phrenic nerve stimulation. A 77-year-old woman was ...

A 53-year-old German man became the first person to undergo a new, non-surgical technique that turned one of his coronary veins into a coronary artery to bypass a blockage, according to a special ...

A team of London scientists have taken a major step in making the use of artificial veins and arteries in coronary bypass grafts a reality. Researchers have developed artificial graft tissue by ...

Scott Johnstone (left), an associate professor with the Fralin Biomedical Research Institute, and Mark Joseph, a cardiothoracic surgeon with Carilion Clinic, led a study published in the Journal of ...

Our group conducted this study for two purposes: first, to investigate whether the low invasive delivery of MSCs via the coronary vein restores cardiac function in chronic ischemic cardiomyopathy ...

Factors associated with the surgical procedure of bypass grafting, such as vein graft harvesting and handling, and the size and condition of the conduit and target vessel, determine long-term patency ...

Researchers are testing bioengineered veins in two sizes that could soon enable patients with poor veins to go on dialysis, undergo coronary artery bypass graft surgery, and more. Elizabeth Armstrong ...

A three-week-old boy was admitted to the hospital because of cardiac failure with diffuse ventricular hypocontractility and normal cardiac anatomy on echocardiography. Coronary and ventricular ...

A novel device called venous external support (VEST) may lead to increased longevity and durability of saphenous (leg) vein grafting during coronary artery bypass surgery, according to a new trial ...

A 71 year-old female with type II diabetes, hypertension and hypercholesterolaemia was admitted electively for coronary angiography and graft study. She underwent CABG 16 years ago with three grafts ...

After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years compared with placebo, according to late-breaking research presented in a Hot Line ...

In chronic heart stimulation, endocardial pacing leads, both passive with the aid of silicone tines or active screw-in, become firmly attached to implanted sites. The lead body may become attached to ...